Bayer Cash on Hand 2010-2024 | BAYRY | MacroTrends

Bayer Cash on Hand 2010-2024 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for the quarter ending December 31, 2024 was $9.151B, a 21.29% decline year-over-year.

Bayer cash on hand for 2024 was $9.151B, a 21.29% decline from 2023.
Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.
Bayer cash on hand for 2022 was $10.935B, a 16.91% increase from 2021.

Bayer Cash on Hand 2010-2024 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Bayer cash on hand for 2024 was $9.151B, a 21.29% decline from 2023.
Bayer cash on hand for 2023 was $11.627B, a 6.33% increase from 2022.
Bayer cash on hand for 2022 was $10.935B, a 16.91% increase from 2021.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$823.1B
Johnson & Johnson (JNJ)	$380.1B
Novo Nordisk (NVO)	$374.3B
AbbVie (ABBV)	$348.4B
Roche Holding AG (RHHBY)	$259.5B
Novartis AG (NVS)	$218.5B
Merck (MRK)	$216.5B
Pfizer (PFE)	$146.7B
Sanofi (SNY)	$136B
Innoviva (INVA)	$1.1B